|
| 37972738 | A multimodality assessment of the protective capacity of statin therapy in a mouse model of radiation cardiotoxicity. | Radiother Oncol | 2024 |
| 38042669 | The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study. | Clin Oncol (R Coll Radiol) | 2024 |
| 36893820 | A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial). | Int J Radiat Oncol Biol Phys | 2023 |
| 37516365 | Response to, "Statin therapy, cardiac events, and survival in patients with non-small cell lung cancer receiving definitive radiotherapy". | Radiother Oncol | 2023 |
| 37573301 | STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway. | Mol Cancer | 2023 |
| 37348608 | Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study. | Radiother Oncol | 2023 |
| 37105303 | A pulmonary vein atlas for radiotherapy planning. | Radiother Oncol | 2023 |
| 37402060 | Feasibility of home-based exercise training during adjuvant treatment for metastatic castrate-resistant prostate cancer patients treated with an androgen receptor pathway inhibitor (EXACT). | Support Care Cancer | 2023 |
| 34763965 | Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review. | Clin Oncol (R Coll Radiol) | 2022 |
| 35533784 | Murine models of radiation cardiotoxicity: A systematic review and recommendations for future studies. | Radiother Oncol | 2022 |
| 35635803 | <i>In vivo</i> dosimetry in pelvic brachytherapy. | Br J Radiol | 2022 |
| 35394236 | Modulating Tumour Hypoxia in Prostate Cancer Through Exercise: The Impact of Redox Signalling on Radiosensitivity. | Sports Med Open | 2022 |
| 35858729 | Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK. | BMJ Open | 2022 |
| 35941861 | Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans. | Phys Imaging Radiat Oncol | 2022 |
| 36113498 | Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial. | Lancet Oncol | 2022 |
| 35272913 | UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. | Clin Oncol (R Coll Radiol) | 2022 |
| 33160001 | Mini review: Personalization of the radiation therapy management of prostate cancer using MRI-based radiomics. | Cancer Lett | 2021 |
| 33714526 | Brachytherapy Boost in Prostate Cancer: What Does Observational Data Add to the Debate? | Int J Radiat Oncol Biol Phys | 2021 |
| 33608585 | Modulating the unfolded protein response with ONC201 to impact on radiation response in prostate cancer cells. | Sci Rep | 2021 |
| 33772218 | Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort study. | Prostate Cancer Prostatic Dis | 2021 |
| 34823110 | 3D-printed patient-specific pelvis phantom for dosimetry measurements for prostate stereotactic radiotherapy with dominant intraprostatic lesion boost. | Phys Med | 2021 |
| 34639350 | Effects of a Brief E-Learning Resource on Sexual Attitudes and Beliefs of Healthcare Professionals Working in Prostate Cancer Care: A Pilot Study. | Int J Environ Res Public Health | 2021 |
| 34187853 | Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer. | Clin Cancer Res | 2021 |
| 33966327 | Rectal spacers in patients with prostate cancer undergoing radiotherapy: A survey of UK uro-oncologists. | Int J Clin Pract | 2021 |
| 34309580 | Efficacy, Use, and Acceptability of a Web-Based Self-management Intervention Designed to Maximize Sexual Well-being in Men Living With Prostate Cancer: Single-Arm Experimental Study. | J Med Internet Res | 2021 |
| 32146018 | Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. | Eur Urol | 2020 |
| 31874245 | miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA. | Cancer Lett | 2020 |
| 31874108 | Genomics of lethal prostate cancer at diagnosis and castration resistance. | J Clin Invest | 2020 |
| 32029296 | Development of a conceptual framework to improve sexual wellbeing communication in routine prostate cancer care. | Patient Educ Couns | 2020 |
| 31806540 | Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. | Lancet Oncol | 2020 |
| 31651660 | The Risk of Cardiovascular Disease in Prostate Cancer Patients Receiving Androgen Deprivation Therapies. | Epidemiology | 2020 |
| 31940221 | Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. | J Clin Oncol | 2020 |
| 33275109 | The Tablet-Based, Engagement, Assessment, Support, and Sign-Posting (EASSi) Tool for Facilitating and Structuring Sexual Well-Being Conversations in Routine Prostate Cancer Care: Mixed-Methods Study. | JMIR Cancer | 2020 |
| 33003551 | Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate Cancer. | Cancers (Basel) | 2020 |
| 32743555 | Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma. | NAR Cancer | 2020 |
| 32856020 | Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods. | NAR Genom Bioinform | 2020 |
| 32880475 | A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer. | Br J Radiol | 2020 |
| 32699318 | The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs. | Nat Rev Urol | 2020 |
| 30433821 | An evaluation of techniques for dose calculation on cone beam computed tomography. | Br J Radiol | 2019 |
| 31857319 | Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol. | BMJ Open | 2019 |
| 32096496 | Erratum to "Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy" [Tech. Innov. Patient Support Radiat. Oncol. 9 (2019) 35-40]. | Tech Innov Patient Support Radiat Oncol | 2019 |
| 32095594 | Observed high incidence of prostatic calculi with the potential to act as natural fiducials for prostate image guided radiotherapy. | Tech Innov Patient Support Radiat Oncol | 2019 |
| 32095591 | A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypo-fractionated radiotherapy alone for the treatment of localised prostate cancer. | Tech Innov Patient Support Radiat Oncol | 2019 |
| 31878967 | Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging. | Radiat Oncol | 2019 |
| 31428443 | Exercise for advanced prostate cancer: a multicomponent, feasibility, trial protocol for men with metastatic castrate-resistant prostate cancer (EXACT). | Pilot Feasibility Stud | 2019 |
| 31254658 | Computed Tomography-based Radiomics for Risk Stratification in Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2019 |
| 31540791 | Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. | Lancet Oncol | 2019 |
| 31002941 | Stereotactic Body Radiation Therapy Boost for Intermediate-Risk Prostate Cancer: A Phase 1 Dose-Escalation Study. | Int J Radiat Oncol Biol Phys | 2019 |
| 29045551 | Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy. | Ann Oncol | 2018 |
| 30038644 | UK & Ireland Prostate Brachytherapy Practice Survey 2014-2016. | J Contemp Brachytherapy | 2018 |